GOV.UK
Inaccurate TV advertising just one of the complaints upheld by the medicines regulator last year
MHRA has published the 9th edition of the advertising report Delivering High Standards in Medicines Advertising.
MHRA statement in response to Royal United Services Institute (RUSI) report: ON TAP
Press statement in response to RUSI's report on organised crime and the illicit trade in tobacco, alcohol and pharmaceuticals (ON TAP) in the UK.
The Yellow Card Scheme: guidance for healthcare professionals
Details of the Yellow Card Scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Regulator warns against GcMAF made in unlicensed facility in Cambridgeshire
The Medicine and Healthcare products Regulatory Agency (MHRA) are today warning people who may have purchased an unlicensed medicine called GcMAF...
MHRA helps Japanese pharmaceutical company to develop its first European site
It is hoped that the single site will help to improve the lives of patients and their families by developing medicines as quickly as possible.
Latest
-
Suspended and revoked licences for manufacturers and wholesalers of medicines
- updated 27 February 2015
- Decision
-
MHRA network outage - now resolved
- updated 27 February 2015
- News story
-
Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)
- published 25 February 2015
- Open consultation
What we do
The Medicines and Healthcare Products Regulatory Agency regulates medicines and medical devices in the UK.
MHRA is an executive agency, sponsored by the Department of Health.
Documents
Our announcements
-
MHRA network outage - now resolved
- 27 February 2015
- News story
-
Inaccurate TV advertising just one of the complaints upheld by the medicines regulator last year
- 24 February 2015
- Press release
Our consultations
-
Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)
- 25 February 2015
- Open consultation
-
Classification of Nexium Control 20mg Gastro-Resistant
- 27 January 2015
- Consultation outcome
Our publications
-
Suspended and revoked licences for manufacturers and wholesalers of medicines
- 27 February 2015
- Decision
-
Field safety notices: information from medical device manufacturers
- 24 February 2015
- Notice
Our statistics
-
Medicines: licensing time-based performance measures
- 17 February 2015
- Statistics
-
Good clinical practice inspection metrics, 2007 to present
- 18 December 2014
- Statistics
Our management
-
Dr Ian Hudson
Chief Executive
-
Peter Commins
Chief Operating Officer
-
Stephen Inglis
Director of National Institute for Biological Standards and Control (NIBSC)
-
Dr Janet Valentine
Director of Clinical Practice Research Datalink (CPRD)
-
Dr Siu Ping Lam
Director of Licensing
-
Dr June Raine
Director of Vigilance and Risk Management of Medicines
-
Gerald Heddell
Director of Inspection, Enforcement and Standards
-
John Wilkinson
Director of Devices
-
John Quinn
Chief Information Officer
-
Rachel Bosworth
Director of Communications
-
Jonathan Mogford
Director of Policy
-
Vanessa Birchall-Scott
Director of Human Resources
Contact MHRA
General enquiries
151 Buckingham Palace Road
London
SW1W 9SZ
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
Press office
4 T
151 Buckingham Palace Road
Victoria
London
SW1W 9SZ
Email press.office@mhra.gsi.gov.uk
During office hours: 020 3080 7651
Out of office hours: 07770 446 189
Office hours are Monday to Friday, 9am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at twitter.com/mhrapress
Defective Medicines Reporting Centre (DMRC)
Email dmrc@mhra.gsi.gov.uk
Contact form https://www.gov.uk/rep...
DMRC (office hours) 020 3080 6574 (08.45 to 16.45 Monday to Friday)
DMRC (out of office hours) 07795 641532 (urgent calls outside of normal working hours, at weekends or on public holidays)
Regulatory Information Service for Medicines (RIS) - new applications
Email RIS.NA@mhra.gsi.gov.uk
Regulatory Information Service 020 3080 7400
Regulatory Information Service for Medicines (RIS) - clinical trials
Email RIS.CT@mhra.gsi.gov.uk
Regulatory Information Service for Medicines (RIS) 020 3080 7400
General or technical queries 020 3080 6456
MHRA portal enquiries
Email manager.portal@mhra.gsi.gov.uk
Telephone 020 3080 7100
For enquiries about registering and submitting product licence applications using the MHRA portal.
Process licensing (PcL) enquiry line
5-Y
151 Buckingham Palace Road
London
SW1W 9SZ
Email pcl@mhra.gsi.gov.uk
Telephone 020 3080 6844
For enquiries from manufacturing and wholesale dealer licence holders, brokers and active substance manufacturers, importers and disitributors (and their representatives) about their licences.
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request
- Check our previous releases to see if we’ve already answered your question
- Make a new request by contacting us at:
Corporate information
Jobs and contracts